Stock comparison
IDEXX Laboratories
Intuitive Surgical
Scored across Buffett, Graham, Lynch and Greenblatt - plus a side-by-side metric table covering valuation, quality, growth and balance sheet.
IDXX
IDEXX Laboratories
Market cap
$43.63B
Sector
Healthcare
ISRG
Intuitive Surgical
Market cap
$155.76B
Sector
Healthcare
Overall winner
IDEXX Laboratories IDXX
Wins on the combined sum of fit scores across all four strategies. Per-strategy breakdown below.
Fit scores by strategy
| Strategy | IDXX | ISRG | Winner |
|---|---|---|---|
| Warren Buffett | 75B | 64C | IDXX |
| Benjamin Graham | 80A | 89A | ISRG |
| Philip Fisher | 75B | 79B | ISRG |
| Peter Lynch | 71B | 76B | ISRG |
| Joel Greenblatt | 83C | 61C | IDXX |
| Charlie Munger | 87A | 69B | IDXX |
| Terry Smith | 84A | 66B | IDXX |
Side-by-side metrics
| Metric | IDXX | ISRG |
|---|---|---|
| Market cap | $43.63B | $155.76B |
| P/E (TTM) | 39.0x | 50.2x |
| EV/EBIT | 31.6x | 49.9x |
| ROIC (TTM) | 40.66% | 16.49% |
| Gross margin | 62.05% | 66.29% |
| Net margin | 24.63% | 28.15% |
| Revenue CAGR 5y | 7.56% | 15.22% |
| EPS CAGR 5y | 10.79% | 13.68% |
| Debt / Equity | 0.7x | - |
| Dividend yield | 0.0% | 0.0% |
Where each one wins
The metrics with the biggest gap between the two - sorted so the most decisive edges read first.
IDXX leads on
- ROIC (TTM)40.66%vs 16.49%+59%
- EV/EBIT31.6xvs 49.9x+37%
- P/E (TTM)39.0xvs 50.2x+22%
ISRG leads on
- Debt / Equity-vs 0.7x+100%
- Market cap$155.76Bvs $43.63B+72%
- Revenue CAGR 5y15.22%vs 7.56%+50%
- EPS CAGR 5y13.68%vs 10.79%+21%
Related on invest-like
Key terms in this analysis
Educational tool. Fit scores are deterministic projections from public financials onto each investor's published criteria - not personal recommendations or advice.